AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells

被引:53
|
作者
Li, Huiyu [1 ,2 ]
Liu, Zhida [3 ,16 ]
Liu, Longchao [3 ]
Zhang, Hongyi [4 ]
Han, Chuanhui [3 ]
Girard, Luc [1 ,13 ]
Park, Hyunsil [1 ]
Zhang, Anli [3 ]
Dong, Chunbo [3 ]
Ye, Jianfeng [4 ]
Rayford, Austin [5 ,11 ]
Peyton, Michael [1 ]
Li, Xiaoguang [3 ]
Avila, Kimberley [1 ]
Cao, Xuezhi [3 ]
Hu, Shuiqing [7 ]
Alam, Md Maksudul [3 ]
Akbay, Esra A. [3 ]
Solis, Luisa M. [8 ]
Behrens, Carmen [9 ]
Hernandez-Ruiz, Sharia [8 ]
Lu, Wei [8 ]
Wistuba, Ignacio [8 ]
Heymach, John, V [9 ]
Chisamore, Michael [10 ]
Micklem, David [5 ]
Gabra, Hani [5 ]
Gausdal, Gro [5 ]
Lorens, James B. [11 ]
Li, Bo [4 ,12 ]
Fu, Yang-Xin [3 ,12 ]
Minna, John D. [1 ,2 ,13 ,14 ,15 ]
Brekken, Rolf A. [1 ,2 ,6 ,13 ,14 ]
机构
[1] UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, 6000 Harry Hines Blvd, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Canc Biol Grad Program, Dallas, TX 75390 USA
[3] UT Southwestern Med Ctr, Dept Pathol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA
[4] UT Southwestern Med Ctr, Lyda Hill Dept Bioinformat, Dallas, TX 75390 USA
[5] BerGenBio ASA, Bergen, Norway
[6] UT Southwestern Med Ctr, Dept Surg, Dallas, TX 75390 USA
[7] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[10] Merck & Co Inc, Kenilworth, NJ 07033 USA
[11] Univ Bergen, Ctr Canc Biomarkers, Norwegian Ctr Excellence, Dept Biomed, Bergen, Norway
[12] UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA
[13] UT Southwestern Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA
[14] UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
[15] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[16] Shanxi Acad Adv Res & Innovat, Taiyuan 030032, Peoples R China
关键词
DENDRITIC CELLS; I INTERFERON; IMMUNE-RESPONSE; INNATE; KINASE; INHIBITION; RECEPTORS; LKB1;
D O I
10.1016/j.xcrm.2022.100554
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mutations in STK11/LKB1 in non-small cell lung cancer (NSCLC) are associated with poor patient responses to immune checkpoint blockade (ICB), and introduction of a Stk11/Lkb1 (L) mutation into murine lung adenocarcinomas driven by mutant Kras and Trp53 loss (KP) resulted in an ICB refractory syngeneic KPL tumor. Mechanistically this occurred because KPL mutant NSCLCs lacked TCF1-expressing CD8 T cells, a phenotype recapitulated in human STK11/LKB1 mutant NSCLCs. Systemic inhibition of Axl results in increased type I interferon secretion from dendritic cells that expanded tumor-associated TCF1(+)PD-1(+)CD8 T cells, restoring therapeutic response to PD-1 ICB in KPL tumors. This was observed in syngeneic immunocompetent mouse models and in humanized mice bearing STK11/LKB1 mutant NSCLC human tumor xenografts. NSCLC-affected individuals with identified STK11/LKB1 mutations receiving bemcentinib and pembrolizumab demonstrated objective clinical response to combination therapy. We conclude that AXL is a critical targetable driver of immune suppression in STK11/LKB1 mutant NSCLC.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] A comprehensive profile of TCF1~+ progenitor and TCF1~- terminally exhausted PD-1~+CD8~+ T cells in head and neck squamous cell carcinoma:implications for prognosis and immunotherapy
    Dikan Wang
    Juan Fang
    Shuqiong Wen
    Qunxing Li
    Jinming Wang
    Lisa Yang
    Wenxiao Dai
    Huanzi Lu
    Junyi Guo
    Zhongyan Shan
    Wenqiang Xie
    Xiangqi Liu
    Liling Wen
    Jie Shen
    Anxun Wang
    Qianming Chen
    Zhi Wang
    International Journal of Oral Science, 2022, 14 (01) : 91 - 99
  • [32] Terminally Exhausted CD8± T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells
    Chakravarti, Mohona
    Dhar, Sukanya
    Bera, Saurav
    Sinha, Abhipsa
    Roy, Kamalika
    Sarkar, Anirban
    Dasgupta, Shayani
    Bhuniya, Avishek
    Saha, Akata
    Das, Juhina
    Banerjee, Saptak
    Vernekar, Manisha
    Pal, Chiranjib
    Alam, Neyaz
    Datta, Dipak
    Baral, Rathindranath
    Bose, Anamika
    CANCER RESEARCH, 2023, 83 (11) : 1815 - 1833
  • [33] Intratumoral lymphocyte networks harbor TCF1+PD1+progenitor CD8 T cells in lung cancer
    Burger, Megan L.
    Gaglia, Giorgio
    Ritch, Claire C.
    Rammos, Danae
    Dai, Yang
    Crossland, Grace E.
    Tavana, Sara Z.
    Warchol, Simon
    Jaeger, Alex M.
    Naranjo, Santiago
    Coy, Shannon
    Nirmal, Ajit J.
    Krueger, Robert
    Lin, Jia-Ren
    Pfister, Hanspeter
    Sorger, Peter K.
    Jacks, Tyler
    Santagata, Sandro
    CANCER RESEARCH, 2023, 83 (07)
  • [34] Combined blockade of TGF-β and PD-1 restores the function of tumor-infiltrating CD8+ T cells in glioblastoma
    Kim, A. R.
    Park, J.
    Kang, S-G.
    Moon, J. H.
    Kim, E. H.
    Park, S-H.
    Chang, J. H.
    Shin, E-C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1733 - 1733
  • [35] Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer
    Joan Choo
    Ley Fang Kua
    Mu Yar Soe
    Bernadette Reyna Asuncion
    Benjamin Kye Jyn Tan
    Chong Boon Teo
    Ryan Yong Kiat Tay
    Jimmy So
    Asim Shabbir
    Kim Guowei
    Hon Lyn Tan
    Gloria Chan
    Haoran Ma
    Gokula Krishnan Ramachandran
    Jeffrey H. Y. Lum
    Cheng Ean Chee
    Sriram Sridharan
    Patrick Tan
    Raghav Sundar
    Wei Peng Yong
    Gastric Cancer, 2023, 26 : 393 - 404
  • [36] Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer
    Best, Sarah A.
    Gubser, Patrick M.
    Sethumadhavan, Shalini
    Kersbergen, Ariena
    Abril, Yashira L. Negron
    Goldford, Joshua
    Sellers, Katherine
    Abeysekera, Waruni
    Garnham, Alexandra L.
    McDonald, Jackson A.
    Weeden, Clare E.
    Anderson, Dovile
    Pirman, David
    Roddy, Thomas P.
    Creek, Darren J.
    Kallies, Axel
    Kingsbury, Gillian
    Sutherland, Kate D.
    CELL METABOLISM, 2022, 34 (06) : 874 - +
  • [37] Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer
    Choo, Joan
    Kua, Ley Fang
    Soe, Mu Yar
    Asuncion, Bernadette Reyna
    Tan, Benjamin Kye Jyn
    Teo, Chong Boon
    Tay, Ryan Yong Kiat
    So, Jimmy
    Shabbir, Asim
    Guowei, Kim
    Tan, Hon Lyn
    Chan, Gloria
    Ma, Haoran
    Ramachandran, Gokula Krishnan
    Lum, Jeffrey H. Y.
    Chee, Cheng Ean
    Sridharan, Sriram
    Tan, Patrick
    Sundar, Raghav
    Yong, Wei Peng
    GASTRIC CANCER, 2023, 26 (03) : 393 - 404
  • [38] Salmonella impairs CD8 T cell response through PD-1: PD-L axis
    Lopez-Medina, Marcela
    Carrillo-Martin, Ismael
    Leyva-Rangel, Jessica
    Alpuche-Aranda, Celia
    Ortiz-Navarrete, Vianney
    IMMUNOBIOLOGY, 2015, 220 (12) : 1369 - 1380
  • [39] Co-inhibition of adenosine signalling and PD-1 restores exhausted CD8 T cells during chronic HIV infection
    Jing, L.
    Tu, B.
    Zhou, M.
    Cao, W.
    Song, J.
    Zhang, C.
    Wang, F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1044 - 1044
  • [40] CD28 signaling strength regulates the cell fate of TCF-1+ PD-1+ CD8 T cells
    Humblin, Etienne
    Van der Heide, Verena
    Filipescu, Dan
    Lu, Ashley
    Selvan, Myvizhi
    Gumus, Zeynep
    Bernstein, Emily
    Chipuk, Jerry
    Homann, Dirk
    Kamphorst, Alice O.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):